1. Home
  2. OIS vs INBX Comparison

OIS vs INBX Comparison

Compare OIS & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oil States International Inc.

OIS

Oil States International Inc.

HOLD

Current Price

$6.89

Market Cap

406.3M

Sector

Industrials

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$79.27

Market Cap

430.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OIS
INBX
Founded
1995
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
406.3M
430.2M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
OIS
INBX
Price
$6.89
$79.27
Analyst Decision
Hold
Hold
Analyst Count
1
2
Target Price
$6.50
N/A
AVG Volume (30 Days)
696.7K
242.1K
Earning Date
10-31-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
N/A
Revenue
$655,119,000.00
$1,400,000.00
Revenue This Year
N/A
$563.00
Revenue Next Year
$3.51
N/A
P/E Ratio
$17.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$10.81
52 Week High
$7.19
$94.57

Technical Indicators

Market Signals
Indicator
OIS
INBX
Relative Strength Index (RSI) 54.62 48.06
Support Level $6.74 $76.22
Resistance Level $7.14 $94.57
Average True Range (ATR) 0.21 6.98
MACD -0.03 -1.37
Stochastic Oscillator 37.07 21.45

Price Performance

Historical Comparison
OIS
INBX

About OIS Oil States International Inc.

Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: